Center for Scientific Review; Notice of Closed Meeting, 71326 [05-23349]
Download as PDF
<![CDATA[
71326
Federal Register / Vol. 70, No. 227 / Monday, November 28, 2005 / Notices
Dated: November 18, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23342 Filed 11–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Kidney,
Nutrition, Obesity and Diabetes (KNOD)
Member Conflicts.
Date: November 28, 2005.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mary Ann Guadagno,
PhD., Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3170, MSC 7770, Bethesda, MD 20892,
(301) 451–8011, guadagma@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Endothelial
Dysfunction Special Emphasis Panel.
Date: November 30, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lawrence E. Boerboom,
PhD., Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5156, MSC 7814, Bethesda, MD 20892,
(301) 435–8367, boerboom@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Aug<31>2005
15:28 Nov 25, 2005
Jkt 208001
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Energy and
Glucose Homeostasis.
Date: December 2, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ann A. Jerkins, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6154,
MSC 7892, Bethesda, MD 20892, 301–435–
4514, jerkinsa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Projects with NCBCs.
Date: December 4–5, 2005.
Time: 7:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Malgorzata Klosek, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7849, Bethesda, MD 20892, (301) 435–
2211, klosekm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Center for Scientific Review Special
Emphasis Panel, Quiescence Program Project.
Date: December 6, 2005.
Time: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Charles R. Dearolf, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142,
MSC 7840, Bethesda, MD 20892, 301–435–
1024, dearolfc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: November 16, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23349 Filed 11–25–05; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Call Monitoring of National
Suicide Prevention Lifeline Form—
NEW
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Mental Health
Services has funded a National Suicide
Prevention Lifeline Network, consisting
of a single toll-free telephone number
that routes calls from anywhere in the
United States to a network of local crisis
centers. In turn, the local centers link
callers to local emergency, mental
health, and social service resources.
To ensure quality, the vast majority of
crisis centers conduct on-site
monitoring of selected calls by
supervisors or trainers using
unobtrusive listening devices. To
monitor the quality of calls and to
inform the development of training for
networked crisis centers, the National
Suicide Prevention Lifeline propose to
remotely monitor calls routed to seven
crisis centers during the shifts of
consenting staff. The procedure will be
anonymous, in that neither staff nor
callers will be identified on the Call
Monitoring Form. The monitor, a
trained crisis worker, will code the type
of problem presented by the caller, the
elements of a suicide risk assessment
that are completed by the crisis worker,
as well as what action plan is developed
with and/or what referral(s) are
provided to the caller. No centers will
be identified in reports.
During the shifts of consenting crisis
staff, a recording will inform callers that
some calls may be monitored for quality
assurance purposes. Previous
comparisons of matched centers that did
and did not play the recording found no
difference in hang-up rates before the
calls were answered or within the first
15 seconds of the calls.
The seven centers to be monitored
will be selected based on the geographic
region(s) they serve. Once a center has
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 70, Number 227 (Monday, November 28, 2005)]
[Notices]
[Page 71326]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-23349]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Kidney, Nutrition, Obesity and Diabetes (KNOD) Member
Conflicts.
Date: November 28, 2005.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Mary Ann Guadagno, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, MSC 7770, Bethesda, MD
20892, (301) 451-8011, guadagma@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Endothelial Dysfunction Special Emphasis Panel.
Date: November 30, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lawrence E. Boerboom, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156, MSC 7814, Bethesda, MD
20892, (301) 435-8367, boerboom@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Energy and Glucose Homeostasis.
Date: December 2, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ann A. Jerkins, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6154, MSC 7892, Bethesda, MD
20892, 301-435-4514, jerkinsa@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative Projects with NCBCs.
Date: December 4-5, 2005.
Time: 7:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Malgorzata Klosek, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188, MSC 7849, Bethesda, MD
20892, (301) 435-2211, klosekm@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Center for Scientific Review Special Emphasis Panel, Quiescence
Program Project.
Date: December 6, 2005.
Time: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Charles R. Dearolf, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD
20892, 301-435-1024, dearolfc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: November 16, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23349 Filed 11-25-05; 8:45 am]
BILLING CODE 4140-01-M
